loading

Rhythm Pharmaceuticals Inc Azioni (RYTM) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
7.15%
25.97
24.23 22.50 19.22 11.47
Cost Of Revenue
13.18%
2.807
3.233 2.412 2.236 1.421
Gross Profit
10.28%
23.16
21.00 20.09 16.98 10.05
Operating Expenses
161.86%
163.05
62.27 64.05 63.59 62.58
Interest Income/Expense
4.51%
4.755
4.55 3.149 3.303 3.061
Benefits Costs and Expenses
154.36%
167.04
65.67 66.30 65.83 63.65
Costs And Expenses
153.22%
165.85
65.50 66.46 65.83 64.00
Operating Income/Loss
239.00%
-139.89
-41.27 -43.95 -46.60 -52.53
Nonoperating Income/Loss
588.95%
-1.185
-0.172 0.158 -0.099 0.352
Income/Loss From Continuing Operations Before Tax
240.45%
-141.07
-41.44 -43.80 -46.70 -52.18
Income Tax Expense/Benefit
53.06%
0.30
0.196 0.368 - -
Income/Loss From Continuing Operations After Tax
239.57%
-141.37
-41.63 -44.16 -46.70 -52.18
Net Income/Loss
239.57%
-141.37
-41.63 -44.16 -46.70 -52.18
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
11,503%
60.14
0.5183 57.87 56.87 56.71
Basic Earnings Per Share
235.71%
-2.35
-0.70 -0.76 -0.82 -0.92
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Capitalizzazione:     |  Volume (24 ore):